+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Intragastric Balloon Market By Administration, By Type, By Filling Material, By End Use, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5026283
  • Report
  • April 2020
  • Region: Asia Pacific
  • 81 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Apollo Endosurgery, Inc.
  • Districlass Medical SA
  • Medsil
  • Obalon Therapeutics, Inc.
  • ReShape Lifesciences Inc.
  • Spatz FGIA, Inc.
The Asia Pacific Intragastric Balloon Market is expected to witness market growth of 13.7% CAGR during the forecast period (2020-2026).

Intragastric balloon technological advancements to provide effective treatment are expected to fuel the market growth during the forecast period. Advances in reducing adverse effects such as gastric erosion, ulceration, and vomiting can promote growth in business. For example, novel systems such as Spatz adjustable balloon and ReShape Duo are specifically designed with antimigration properties which prevent migration and allow adjustment of the volume of the balloon. These advancements is expected to accelerate the growth of the intragastric balloon industry over the projected period.

Owing to growing cases of obesity, the Australian intragastric balloon market accounted for a dominant market share in the regional market. More than 60 percent of the Australian population is suffering from obesity, according to the Australia & New Zealand Mental Health Association (ANZMH). A high prevalence of obesity is attributed to following a sedentary lifestyle, thereby propelling growth in the market.

Intragastric balloon surgery in India is one of the most popular procedures for obesity surgery carried out by patients from outside the world. India's hospitals and health-care services are outstanding in terms of cost and efficiency. This surgery comes with the best medical treatment to gain from weight loss. There are advanced hospitals and the best-trained doctors in India's medical infrastructure. With the best facilities, high-quality medical services, followed by the most affordable prices, the hospitality and treatment for Intragastric balloon treatment in India fascinate international patients.

Based on Administration, the market is segmented into Endoscopy and Pill Form. Based on Type, the market is segmented into Single, Dual and Triple. Based on Filling Material, the market is segmented into Gas Filled and saline Filled. Based on End Use, the market is segmented into Clinics, Hospitals and Ambulatory Surgical Centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil

Scope of the Study

Market Segmentation:

By Administration
  • Endoscopy and
  • Pill Form

By Type
  • Single
  • Dual and
  • Triple

By Filling Material
  • Gas Filled and
  • Saline Filled

By End Use
  • Clinics
  • Hospitals and
  • Ambulatory Surgical Centers

By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled:
  • Sientra, Inc. (Silimed, Inc.)
  • Apollo Endosurgery, Inc.
  • Obalon Therapeutics, Inc.
  • ReShape Lifesciences Inc.
  • Allurion Technologies, Inc.
  • Helioscopie SA (Sante Actions Group)
  • Districlass Medical SA
  • Spatz FGIA, Inc.
  • Duomed Group (Life Partners Europe)
  • Medsil

Unique Offerings from the Publisher:
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Apollo Endosurgery, Inc.
  • Districlass Medical SA
  • Medsil
  • Obalon Therapeutics, Inc.
  • ReShape Lifesciences Inc.
  • Spatz FGIA, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Intragastric Balloon Market, by Administration
1.4.2 Asia Pacific Intragastric Balloon Market, by Type
1.4.3 Asia Pacific Intragastric Balloon Market, by Filling Material
1.4.4 Asia Pacific Intragastric Balloon Market, by End Use
1.4.5 Asia Pacific Intragastric Balloon Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Intragastric Balloon Market by Administration
3.1 Asia Pacific Endoscopy Market by Country
3.2 Asia Pacific Pill Form Market by Country
Chapter 4. Asia Pacific Intragastric Balloon Market by Type
4.1 Asia Pacific Single Market by Country
4.2 Asia Pacific Dual Market by Country
4.3 Asia Pacific Triple Market by Country
Chapter 5. Asia Pacific Intragastric Balloon Market by Filling Material
5.1 Asia Pacific Gas Filled Intragastric Balloon Market by Country
5.2 Asia Pacific Saline Filled Intragastric Balloon Market by Country
Chapter 6. Asia Pacific Intragastric Balloon Market by End-use
6.1 Asia Pacific Clinics Intragastric Balloon Market by Country
6.2 Asia Pacific Hospitals Market by Country
6.3 Asia Pacific Ambulatory Surgical Centers Market by Country
Chapter 7. Asia Pacific Intragastric Balloon Market by Country
7.1 China Intragastric Balloon Market
7.1.1 China Intragastric Balloon Market by Administration
7.1.2 China Intragastric Balloon Market by Type
7.1.3 China Intragastric Balloon Market by Filling Material
7.1.4 China Intragastric Balloon Market by End-use
7.2 Japan Intragastric Balloon Market
7.2.1 Japan Intragastric Balloon Market by Administration
7.2.2 Japan Intragastric Balloon Market by Type
7.2.3 Japan Intragastric Balloon Market by Filling Material
7.2.4 Japan Intragastric Balloon Market by End-use
7.3 India Intragastric Balloon Market
7.3.1 India Intragastric Balloon Market by Administration
7.3.2 India Intragastric Balloon Market by Type
7.3.3 India Intragastric Balloon Market by Filling Material
7.3.4 India Intragastric Balloon Market by End-use
7.4 South Korea Intragastric Balloon Market
7.4.1 South Korea Intragastric Balloon Market by Administration
7.4.2 South Korea Intragastric Balloon Market by Type
7.4.3 South Korea Intragastric Balloon Market by Filling Material
7.4.4 South Korea Intragastric Balloon Market by End-use
7.5 Singapore Intragastric Balloon Market
7.5.1 Singapore Intragastric Balloon Market by Administration
7.5.2 Singapore Intragastric Balloon Market by Type
7.5.3 Singapore Intragastric Balloon Market by Filling Material
7.5.4 Singapore Intragastric Balloon Market by End-use
7.6 Malaysia Intragastric Balloon Market
7.6.1 Malaysia Intragastric Balloon Market by Administration
7.6.2 Malaysia Intragastric Balloon Market by Type
7.6.3 Malaysia Intragastric Balloon Market by Filling Material
7.6.4 Malaysia Intragastric Balloon Market by End-use
7.7 Rest of Asia Pacific Intragastric Balloon Market
7.7.1 Rest of Asia Pacific Intragastric Balloon Market by Administration
7.7.2 Rest of Asia Pacific Intragastric Balloon Market by Type
7.7.3 Rest of Asia Pacific Intragastric Balloon Market by Filling Material
7.7.4 Rest of Asia Pacific Intragastric Balloon Market by End-use
Chapter 8. Company Profiles
8.1 Sientra, Inc. (Silimed, Inc.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Apollo Endosurgery, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals:
8.3 Obalon Therapeutics, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.3.5.2 Partnerships, Collaborations, and Agreements:
8.3.5.3 Geographical Expansions:
8.4 ReShape Lifesciences, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research and Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Allurion Technologies, Inc.
8.5.1 Company Overview
8.6 Helioscopie SA (Sante Actions Group)
8.6.1 Company Overview
8.7 Districlass Medical SA
8.7.1 Company Overview
8.8 Spatz FGIA, Inc.
8.8.1 Company Overview
8.9 Duomed Group (Life Partners Europe)
8.9.1 Company Overview
8.1 Medsil
8.10.1 Company Overview
Note: Product cover images may vary from those shown
  • Sientra, Inc. (Silimed, Inc.)
  • Apollo Endosurgery, Inc.
  • Obalon Therapeutics, Inc.
  • ReShape Lifesciences Inc.
  • Allurion Technologies, Inc.
  • Helioscopie SA (Sante Actions Group)
  • Districlass Medical SA
  • Spatz FGIA, Inc.
  • Duomed Group (Life Partners Europe)
  • Medsil
Note: Product cover images may vary from those shown

Loading
LOADING...